Type 2 diabetes: open trials in United Arab Emirates

5 open trials have a site in United Arab Emirates. Registry data; only the trial team decides who can take part.

NCT07613307
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Trial Treatment · Phase 3 · Eli Lilly and Company
Sheikh Khalifa Medical City, Abu Dhabi · NMC Abu Dhabi, Abu Dhabi · NMC Royal hospital, Abu Dhabi · Burjeel Medical City, Abu Dhabi · Tawam Hospital, Al Ain City · Dubai Hospital, Dubai · Emirates Hospital Dubai, Dubai
Registry updated 2026-10-08
NCT03549754
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Research · AstraZeneca
Sharjah city
Registry updated 2026-09-09
NCT07742917
Precision Lifestyle Medicine Program for IFHAS Participants
Trial Treatment · Institute for Healthier Living Abu Dhabi
Institute for Healthier Living, Abu Dhabi
Registry updated 2026-08-03
NCT06605508
Regenerative Injection of Stem Cells or Stem Cell-derived Exosomes for Erectile Dysfunction (RISE)
Research · Jumeirah American Clinic
Jumeirah American Clinic, Dubai
Registry updated 2025-08-26
NCT06590324
A Study of Apabetalone in Subjects With Long -COVID
Trial Treatment · Phase 2/3 · Resverlogix Corp
Al Kuwait Hospital, Dubai
Registry updated 2025-04-18

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting